NASH (Non–Alcoholics Steatohepatitis) Market Growing at 25.56% by 2030

ReportsnReports.com adds Global NASH (Non–Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) (By Region, By Drugs – Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market) report in its store.

December 16, 2015 /MarketersMedia/ —

Progressive numbers of Liver disorders along with rise in obesity will fuel the demand for NASH Drugs.

The Global NASH Market is growing at a moderate rate over last five years on account of rising number of obesity among young population. NASH (non-alcoholic steatohepatitis) is a large, un-tapped market with no FDA approved therapeutics. Antioxidants, anti-diabetic medications, anti-obesity medications and antihyper Lipidemics are some of the off-label products currently used by NASH patients. Moreover, increase in number of patients suffering from fat in liver disorder is further anticipated to boost the Global NASH market in the coming years.

Browse 43 data figures spread through 112 pages and in-depth TOC on “Global NASH (Non–Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) (By Region, By Drugs – Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market)” at http://www.reportsnreports.com/reports/447019-global-nash-non-alcoholics-steatohepatitis-market-trends-opportunities-and-forecasts-2015-2030-by-region-by-drugs-off-label-special-treatment-drugs-aramachol-clinical-pipeline-gr-md-02-gft-505-market-.html.

According to Analytics research report, “Global NASH (Non –Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) – (By Region, By Drugs – Off Label & Special Treatment, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market)”, global non-alcoholic steatohepatitis drug specific market is estimated to start growing by 2020 at a CAGR of 25.56% during 2020-2030, due to the projected product launches in 2020. Surge in cycles of clinical trials and their success rate has improved the probability of industries receiving commercial approval for NASH therapeutics by the end of 2020. Additionally, the absence of efficient diagnostic technologies acts as a major hurdle for the research of NASH therapeutics.

Nevertheless, the emergence of novel biomarker technologies and improvements in liver biopsy technologies are expected to bring about an evolution in the diagnosis of NASH and other fatty liver diseases. Despite of these challenges, certain key players such as Galmed Pharmaceuticals, Gilead Sciences, Novo Nordisk, Genfit, Intercept and Galectin Therapeutics are conducting extensive research on NASH therapeutics and are receiving positive results from clinical trials. But, the low diagnosis rates, low prescription rates and low treatment seeking rates continue to pose significant challenges for these emerging players. The United States, which has the highest number of research initiatives concerning NASH, holds nearly half of the global market share. The chief reason behind this growth is the high prevalence of diabetes and obesity and the growing number of people suffering with these conditions. The US has the highest number cases of NASH and other non-alcoholic fatty liver diseases.

Order a Copy of Global NASH (Non–Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) (By Region, By Drugs – Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market) Report at http://www.reportsnreports.com/purchase.aspx?name=447019.

Scope of the Report:
Global NASH (Non –Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) – (By Region, By Drugs – Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market) analyses the following aspects of global Alzheimer’s market:
• Global NASH Market Size, Share & Forecast
• Segmental Analysis – By off Label , By Specific Drug and By Patient
• Policy & Regulatory Landscape
• Changing Market Trends & Emerging Opportunities
• Competitive Landscape & Strategic Recommendations

Major Points from Table of Content:
1. Research Methodology
2. Executive Summary
3. Global NASH Market: An Analysis
4. Country Analysis
5. The US NASH Market by Therapeutics
6. Regional Analysis
7. Country Overview
8. Clinical Pipeline Analysis of NASH Drugs
9. Market Dynamics
10. Competitive Landscape
11. 43 – List of Figures

Explore other reports by Azoth Analytics Market at http://www.reportsnreports.com/publisher/azoth-analytics/.

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

A 24/7 online and offline support is provided to the customers.

For more information about us, please visit http://www.reportsnreports.com/reports/447019-global-nash-non-alcoholics-steatohepatitis-market-trends-opportunities-and-forecasts-2015-2030-by-region-by-drugs-off-label-special-treatment-drugs-aramachol-clinical-pipeline-gr-md-02-gft-505-market-.html

Contact Info:
Name: Ritesh Tiwari
Email: sales@reportsandreports.com
Organization: ReportsnReports.com
Phone: + 1 888 391 5441

Source: http://marketersmedia.com/nash-non-alcoholics-steatohepatitis-market-growing-at-25-56-by-2030/99263

Release ID: 99263